Class | Name/Company | Approval Dates and Comments |
Antiviral Agents |
GlaxoSmithKline |
The US FDA approved a shorter course of therapy for this antiherpes |
Anti-acne Agents |
AP Phrama/Johnson & Johnson Canada |
TPP – Canada approved this gel for marketing in Canada in July |
Oral Contraceptive |
Berlex |
The US FDA approved this low-dose monophasic, oral contraceptive |
Enzyme Replacement Therapy |
Genzyme |
The European Commission of the European Union granted marketing |
Drug News | |
Antibacterial Agents |
In a double-blind, placebo-controlled trial, recently reported in the New England Journal of Medicine*, the |
Immunosuppressors |
Rapamune® (Sirolimus, Wyeth-Ayerst Laboratories), a transplant immunosuppressant, became available in |
Herbal Preparations |
In an article published in the Journal of the American Medical Association*, Ang-Lee, et al, reviewed the |